Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memory, Ageing, and the Cholinergic System
DRKS00000780Phase 2Completed
- Sponsor
- University Hospital Cologne
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rivastigmine in cognitive disorder (CD) and Mild Cognitive Impairment (MCI) (4 arms), sponsored by University Hospital Cologne. Started Mar 2011; status: completed.
02
Drugs
rivastigmine
03
Conditions
cognitive disorder (CD)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on DRKS00000780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000780.